Ameritas Investment Partners’s Guardant Health GH Stock Holding History

Ameritas Investment Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$939K	Buy	10,166 +132	+1%	+$13.3K	0.03%	627
2025 Q4	$1.02M	Buy	10,034 +54	+0.5%	+$4.83K	0.03%	604
2025 Q3	$624K	Sell	9,980 -2,216	-18%	-$121K	0.02%	747
2025 Q2	$635K	Buy	12,196 +162	+1%	+$7.24K	0.02%	752
2025 Q1	$513K	Sell	12,034 -312	-3%	-$13.5K	0.02%	807
2024 Q4	$377K	Buy	12,346 +391	+3%	+$11K	0.01%	961
2024 Q3	$274K	Buy	11,955 +692	+6%	+$19.6K	0.01%	1126
2024 Q2	$325K	Sell	11,263 -430	-4%	-$10K	0.01%	975
2024 Q1	$241K	Hold	11,693	–	–	0.01%	1164
2023 Q4	$316K	Buy	11,693 +644	+6%	+$16.9K	0.01%	993
2023 Q3	$327K	Buy	11,049 +1,866	+20%	+$65.6K	0.01%	924
2023 Q2	$329K	Buy	+9,183	New	+$264K	0.01%	902
2019 Q2	–	Sell	-1,196	Closed	-$92K	–	3075
2019 Q1	$92K	Hold	1,196	–	–	﹤0.01%	1529
2018 Q4	$45K	Buy	+1,196	New	+$44.1K	﹤0.01%	1874

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Partners's GH Position: Q1 2026 in Review

Ameritas Investment Partners increased its Guardant Health (GH) stake by 1.3% in Q1 2026, buying an estimated $13.3K and bringing the position to 10,166 shares worth $939K. The position accounts for 0.03% of the portfolio, ranked #627.

Ameritas Investment Partners first reported a position in GH in Q4 2018 and has held it in 14 quarters since. The position peaked at $1.02M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Ameritas Investment Partners held 10,166 shares of Guardant Health worth $939K as of Q1 2026.
Ameritas Investment Partners bought 132 Guardant Health shares in Q1 2026, an estimated $13.3K.
Guardant Health made up 0.03% of Ameritas Investment Partners's portfolio in Q1 2026, its #627 holding.
Ameritas Investment Partners first reported a position in Guardant Health in Q4 2018 and has held it in 14 quarters since.
Ameritas Investment Partners's Guardant Health position peaked at $1.02M in Q4 2025.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.